A research scientist at the University of California, Los Angeles recently received a $5.1 million life science grant for stem cell research from the California Institute of Regenerative Medicine. California’s state stem cell agency awarded the new research funding to UCLA’s Dr. John Chute so that he may further his investigations into creating new stem cell therapies in the medical field.
Dr. Chute is a professor of hematology-oncology within the departments of medicine and radiation oncology at the University of California, Los Angeles. The new life science grant recognizes his progressive research in hematopoietic stem cells, or cells that become blood cells, and the process behind how they grow. Dr. Chute and his team of research scientists also focus their efforts on understanding how cells in the bone-marrow microenvironment regulate HSC self-renewal, repair and regeneration.
Dr. John Chute
Image courtesy of UCLA
"We’ve shown that our approach of creating genetic mouse models to find proteins that regulate HSC growth works," Dr. Chute said. "We are now poised to translate some of these into Phase I clinical trials. Thus, there is strong translational value in our work and it is a validated discovery program for understanding how the microenvironment cells regulate HSC in the body."
This new life science grant will go a long way in aiding Dr. Chute meet his research goals. Stem cell therapies are a constantly evolving field with great potential to improve the lives of millions of patients suffering from a vast array of harmful diseases.
The University of California, Los Angeles has received over $1 billion in new research funding per year over the last three years. In FY 2013-2014 year to date, the University of California, Los Angeles has received $825.6 million in new research funding. A new, $120 million Teaching and Learning Center for the Health Sciences is also under construction at the University of California, Los Angeles. The 110,000 square-foot facility is expected to be complete in 2016. The University of California, Los Angeles receives a great deal of funding from organizations such as the NIH. In 2013, the UCLA Clinical and Translational Science Institute received $13.3 million from the National Institutes of Health.
If you are a lab supplier interested in turning lab sales leads into sales in California, Biotechnology Calendar, Inc. invites you to attend our UCLA life science vendor show. Our Biotechnology Vendor Showcase™ Event at the University of California, Los Angeles will take place on October 9th, 2014. Last year, this life science vendor show attracted 626 attendees. Of these attendees, 152 were purchasing agents, professors and post docs, and 79 were lab managers.
UCLA life science vendor show video
Biotechnology Calendar, Inc. is a full-service science research marketing and events-planning company that organizes life science vendor shows at top research universities across the country. If you would like to exhibit at a university closer to home, we encourage you to view our 2014 calendar of events. For more funding statistics on the University of California, Los Angeles, or to learn more about our UCLA life science vendor show, click on the button below.